Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylene Glycol SCHEMBL161401 | 1.00 | TDP1 (1.00) | — | |
| Propylene Glycol SCHEMBL28578 | 1.00 | — | — | |
| Propylene Glycol SCHEMBL724028 | 1.00 | TDP1 (1.00) | — | |
| Propylene Glycol SCHEMBL7522896 | 1.00 | TDP1 (1.00) | — | |
| Propylene Glycol SCHEMBL3535 | 1.00 | — | — | |
| Propylene Glycol SCHEMBL29873191 | 1.00 | — | — | |
| Propylene Glycol SCHEMBL15864609 | 1.00 | TDP1 (1.00) | — | |
| Propylene Glycol SCHEMBL25230484 | 0.95 | — | — | |
| Propylene Glycol SCHEMBL9240018 | 0.95 | — | — | |
| Propylene Glycol SCHEMBL11347249 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2149 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3823631-B1 | METHODS OF TREATING HFPEF EMPLOYING DAPAGLIFLOZIN AND COMPOSITIONS COMPRISING THE SAME | ASTRAZENECA AB (SE) | 2026-05-20 | — | — | EP | claimed |
| EP-4739697-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zaklady Farmaceutyczne Polpharma S.A. (PL) | 2026-05-13 | — | — | EP | claimed |
| US-12480061-B2 | System and method for liquid fuel production from carbonaceous materials using recycled conditioned syngas | THERMOCHEM RECOVERY INTERNATIONAL, INC. (US) | 2025-11-25 | — | — | US | claimed |
| US-20250302782-A1 | ADMINISTRATION OF BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS FOR THE TREATMENT AND/OR PREVENTION OF RESPIRATORY ILLNESSES | AXCESS GLOBAL SCIENCES, LLC | 2025-10-02 | — | — | US | claimed |
| EP-4188389-B1 | DAPAGLIFLOZIN FOR USE IN METHODS OF TREATING CHRONIC KIDNEY DISEASE | ASTRAZENECA AB (SE) | 2025-09-17 | — | — | EP | claimed |
| WO-2025125513-A1 | SGLT2 INHIBITORS AND BAXDROSTAT FOR TREATING CHRONIC KIDNEY DISEASE AND HYPERTENSION | AstraZeneca Ireland Limited (IE) | 2025-06-19 | — | — | WO | claimed |
| US-20250108065-A1 | METHODS OF TREATING PREDIABETES OR REDUCING THE RISK OF DEVELOPING TYPE 2 DIABETES WITH DAPAGLIFLOZIN | ASTRAZENECA AB (SE) | 2025-04-03 | — | — | US | claimed |
| CN-109892321-B | Low-temperature preservation method for large-volume biological sample | 中国科学技术大学 | 2025-03-28 | — | — | CN | claimed |
| CN-113897414-B | Trace nucleic acid library construction method | 湖南大地同年生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| WO-2025008539-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zakłady Farmaceutyczne POLPHARMA S.A. (PL) | 2025-01-09 | — | — | WO | claimed |
| US-6727088-B2 | GENERATION OF (R)-1,-2-PROPANEDIOL; OBTAIN MICROORGANISM WHICH PREFERENTIALLY UTILIZES S-1,-2-PROPANEDIOL, PROPAGATE IN A SOLUTION CONTAINING RACEMIC MIXTURE OF 1,2 PROPANEDIOL, RECOVER R-1,-2-PROPANEDIOL | DAISO CO., LTD. (JP) | 2004-04-27 | — | — | US | claimed |
| WO-2003083126-A2 | ENZYMATIC RESOLUTION OF PROPYLENE GLYCOL ALKYL (OR ARYL) ETHERS AND ETHER ACETATES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-10-09 | — | — | WO | claimed |
| US-20020132314-A1 | Process for preparation of (R)-1,-2-propanediol by microbes | DAISO CO., LTD. (JP) | 2002-09-19 | — | — | US | claimed |
| US-20020119909-A1 | Preparation of enantiomerically enriched flavor and fragrance components | RHODIA CHIREX, INC. | 2002-08-29 | — | — | US | claimed |
| WO-2002057227-A2 | PROCESS OF ENANTIOMERICALLY ENRICHED FLAVOR AND FRAGRANCE COMPONENTS | RHODIA/CHIREX, INC. (US) | 2002-07-25 | — | — | WO | claimed |
| WO-2002051395-A1 | TREATMENT OF NEURODEGENERATIVE DISEASES | CODON PHARMACEUTICALS, INC. (US) | 2002-07-04 | — | — | WO | claimed |
| EP-1219715-A1 | Process for preparation of (R)-1,2-propanediol by microbes | DAISO CO., LTD. (JP) | 2002-07-03 | — | — | EP | claimed |
| US-5990177-A | CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM | CODON PHARMACEUTICALS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| US-4945187-A | REDUCING LACTIDE | KARL THOMAE GMBH (DE) | 1990-07-31 | — | — | US | claimed |
| EP-0350852-A1 | Process for the production of enantiomer-pure propane 1,2-diols | BOEHRINGER INGELHEIM KG (DE) | 1990-01-17 | — | — | EP | claimed |